Clinical Translation Initiative
Ontario is among the world’s leaders in developing and leading cell therapy clinical trials. With 13 trials currently ongoing or launching soon (see graphic below and more details here), when compared to other leading areas, Ontario achieves more, with less. This is due to a favourable environment for clinical trials here in Ontario, our leading research institutes and hospitals and the efforts of organizations like OIRM and its partners.
In 2015, OIRM formed a Clinical Translation Initiative, based on the expertise of its researchers/clinicians who are leading or have led clinical trials in Ontario. The Initiative aims to further develop Ontario’s capacity for clinical trials for the benefit of patients. It hosts workshops focused on problem solving in the areas of regulatory approval, cell manufacturing, access to cells, patient recruitment and registries, reimbursement strategies, and commercialization.